Childhood Hematopoietic and Lymphatic System Neoplasm

2

Review clinical trials related to Childhood Hematopoietic and Lymphatic System Neoplasm. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Study of Strengthening Teen Brain Resilience Using Music During Cancer Treatment

This clinical trial tests the feasibility and acceptability of the Strengthening Teen Brain Resilience Using Music (STRUM) intervention to improve radiation induced cognitive decline for adolescents undergoing radiation therapy for cancer treatment. Adolescents treated with radiation therapy for cancer often experience persistent cognitive deficits and reduced brain resilience or the ability to preserve cognitive and emotional functioning despite stressors. Musical instrument training has been shown to enhance memory, academic skills, and emotional well-being in youth. Although guitars are often the most preferred instrument, ukuleles offer greater accessibility due to their simplicity, affordability, and suitability for younger users. The STRUM intervention consists of virtual active music therapy ukulele lessons, which may be a feasible and acceptable way to improve radiation induced cognitive decline for adolescents undergoing radiation therapy for cancer treatment.

Participants needed: 30
Trial details
Age: 12-17Biological sex: AllType: InterventionalSponsor: Mayo ClinicUpdated: Jul 27, 2026Locations: 1
Eligibility criteria

Aged 12-17 years at the time of enrollment [+4]

Less than three-month prognosis [+4]

Status: Recruiting

Quality of End-of-Life Care for Children With Cancer

This study examines the role of access to care, patient/family interactions with the healthcare system, and stress in explaining variations in quality of end of life care. The data collected from this study may help researchers develop a model for identifying patients at risk of low quality end of life care as well as recommendations for potential future interventions.

Participants needed: 2,425
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Children's Oncology GroupUpdated: Jul 16, 2026Locations: 15
Eligibility criteria

Must be deceased [+12]